Clinical practice guidelines on diagnosis and treatment of hyponatraemia: Response to letter from otsuka Ltd.

European Journal of Endocrinology

Volumn 171, Issue 1, 2014, Pages

  Van Biesen, Wim ^a,b   Vanholder, Raymond ^b,c  

^a Department of European Renal Best Practice ^*  (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c Hyponatraemia Guideline Development Group   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; CALCIMIMETIC AGENT; SODIUM;

DOCUMENTATION; EVIDENCE BASED PRACTICE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LETTER; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; SODIUM BLOOD LEVEL; TREATMENT OUTCOME; VASOPRESSIN RELEASE;

FEMALE; HUMANS; HYPONATREMIA; MALE;

EID: 84903523345     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0393     Document Type: Letter

References (10)

1. Avila M. The Clinical Practice Guideline on diagnosis and treatment of hyponatraemia: a response from Otsuka Pharmaceutical Europe Ltd. European Journal of Endocrinology 2014 171 L1-L3. (doi:10.1530/EJE-14-0392)
2. Nagler EV, Webster AC, Bolignano D, Haller MC, Nistor I, van der Veer SN, Fouque D & Van Biesen W. European Renal Best Practice Guideline development methodology: towards the best possible guidelines. Nephrology, Dialysis, Transplantation 2014 29 731-738. (doi:10.1093/ndt/gft407)
3. Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC, The National Academies Press. 2011
4. Alonso-Coello P, Irfan A, Sol I, Gich I, Delgado-Noguera M, Rigau D, Tort S, Bonfill X, Burgers J & Schunemann H. The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Quality & Safety in Health Care 2010 19 e58. (doi:10.1136/qshc. 2010.042077)
5. AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality & Safety in Health Care 2003 12 18-23. (doi:10.1136/qhc.12.1.18)
6. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn E, Ichai C et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. European Journal of Endocrinology 2014 170 G1-G47. (doi:10.1530/EJE-13-1020)
7. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrology, Dialysis, Transplantation 2014 29 (Suppl 2) i1-i39. (doi:10.1093/ndt/gfu040)
8. Shiffman RN, Dixon J, Brandt C, Essaihi A, Hsiao A, Michel G & O'Connell R. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Medical Informatics and Decision Making 2005 5 23. (doi:10.1186/1472-6947-5-23)
9. van der Veer SN, Tomson CR, Jager KJ & van Biesen W. Bridging the gap between what is known and what we do in renal medicine: improving implementability of the European Renal Best Practice guidelines. Nephrology, Dialysis, Transplantation 2014 29 951-957. (doi:10.1093/ndt/gft496)
10. Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH & Thompson CJ. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. American Journal of Medicine 2013 126 (10 Suppl 1) S1-42. (doi:10.1016/j.amjmed.2013.07.006)